✦ LIBER ✦

Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma – results of a prospective multicentre controlled trial

✍ Scribed by Edgar Faber; Robert Pytlík; Jiří Slabý; Jana Zapletalová; Tomáš Kozák; Luděk Raida; Tomáš Papajík; Eva Žikešová; Ivana Marešová; Marie Hamouzová; Karel Indrák; Marek Trněný

Book ID: 114794093
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 151 KB
Volume: 77
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2006.00741.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegfilgrastim Appears Equivalent to Dail

Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma

✍ Robert Rifkin; Gary Spitzer; Gregory Orloff; Romeo Mandanas; Dean McGaughey; Fen 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 132 KB

Fixed-dose single administration of Pegf

Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation

✍ Staber, P B; Holub, R; Linkesch, W; Schmidt, H; Neumeister, P 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Patients with malignant lymphomas experi

Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation

✍ O. Sezer; J. Eucker; C. Bauhuis; M. Schweigert; D. Lüftner; U. Kalus; E. Späth-S 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 63 KB

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTI

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA

✍ L. Perrier; A. Lefranc; P. Quittet; P. Moreau; C. Siani; H. Ghesquières; F. Jard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Efficacy of single-dose pegfilgrastim af

Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma

✍ Frank Kroschinsky; Kristina Hölig; Uwe Platzbecker; Kirsten Poppe-Thiede; Rainer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is